Total: £ 56.28
Published Date: 2026-04-17 | Pages: 109 | Tables: 101 | Medical Care
The global Automated And Closed Cell Therapy Processing Systems market was valued at US$ 1393 million in 2025 and is anticipated to reach US$ 4996 million by 2032, at a CAGR of 20.3% from 2026 to 2032.
Automated and closed cell therapy processing systems are specialized technologies used in the field of regenerative medicine and cell therapy. These systems refer to the use of automated technology and equipment to perform various steps involved in the manufacturing and processing of cell-based therapies. This includes processes such as cell isolation, expansion, culture, harvesting, and quality control. Automation aims to reduce variability, improve reproducibility, and enhance the efficiency of cell therapy production. By automating these processes, it becomes possible to achieve higher throughput, maintain sterility, and ensure consistency in the final product. Closed systems in cell therapy processing refer to the use of fully enclosed environments and devices that minimize the exposure of cells to the external environment throughout the manufacturing process. Closed systems are critical for maintaining the safety and quality of cell therapies by reducing the risk of microbial contamination and protecting the cells from exposure to harmful agents.
North America is the largest Automated and Closed Cell Therapy Processing Systems market, which has a share about 41%, followed by Asia-Pacific and Europe with a market share of 34% and 24%, respectively. In terms of product type, Non-Stem Cell Therapy is the largest segment, occupied for a share of 90%. And in terms of application, Industry is the largest segment, which has a share about 66%.
This report delivers a comprehensive overview of the global Automated And Closed Cell Therapy Processing Systems market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Automated And Closed Cell Therapy Processing Systems. The Automated And Closed Cell Therapy Processing Systems market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Automated And Closed Cell Therapy Processing Systems market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Automated And Closed Cell Therapy Processing Systems manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Cytiva
Miltenyi Biotec
Thermo Fisher Scientific
Terumo
Merck
Fresenius Kabi
Sartorius
Lonza
Boyalife (ThermoGenesis)
EurekaBio
Segment by Type
Stem Cell Therapy
Non-Stem Cell Therapy
Segment by Application
Academia
Industry
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Automated And Closed Cell Therapy Processing Systems companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Stem Cell Therapy
1.2.3 Non-Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Automated And Closed Cell Therapy Processing Systems Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Academia
1.3.3 Industry
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Automated And Closed Cell Therapy Processing Systems Market Perspective (2021–2032)
2.2 Global Automated And Closed Cell Therapy Processing Systems Growth Trends by Region
2.2.1 Global Automated And Closed Cell Therapy Processing Systems Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Automated And Closed Cell Therapy Processing Systems Historic Market Size by Region (2021–2026)
2.2.3 Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Region (2027–2032)
2.3 Automated And Closed Cell Therapy Processing Systems Market Dynamics
2.3.1 Automated And Closed Cell Therapy Processing Systems Industry Trends
2.3.2 Automated And Closed Cell Therapy Processing Systems Market Drivers
2.3.3 Automated And Closed Cell Therapy Processing Systems Market Challenges
2.3.4 Automated And Closed Cell Therapy Processing Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Automated And Closed Cell Therapy Processing Systems Players by Revenue
3.1.1 Global Top Automated And Closed Cell Therapy Processing Systems Players by Revenue (2021–2026)
3.1.2 Global Automated And Closed Cell Therapy Processing Systems Revenue Market Share by Players (2021–2026)
3.2 Global Top Automated And Closed Cell Therapy Processing Systems Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Automated And Closed Cell Therapy Processing Systems Revenue
3.4 Global Automated And Closed Cell Therapy Processing Systems Market Concentration Ratio
3.4.1 Global Automated And Closed Cell Therapy Processing Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Automated And Closed Cell Therapy Processing Systems Revenue in 2025
3.5 Global Key Players of Automated And Closed Cell Therapy Processing Systems Head Offices and Areas Served
3.6 Global Key Players of Automated And Closed Cell Therapy Processing Systems, Products and Applications
3.7 Global Key Players of Automated And Closed Cell Therapy Processing Systems, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Automated And Closed Cell Therapy Processing Systems Breakdown Data by Type
4.1 Global Automated And Closed Cell Therapy Processing Systems Historic Market Size by Type (2021–2026)
4.2 Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Type (2027–2032)
5 Automated And Closed Cell Therapy Processing Systems Breakdown Data by Application
5.1 Global Automated And Closed Cell Therapy Processing Systems Historic Market Size by Application (2021–2026)
5.2 Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Automated And Closed Cell Therapy Processing Systems Market Size (2021–2032)
6.2 North America Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2021–2026)
6.4 North America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Automated And Closed Cell Therapy Processing Systems Market Size (2021–2032)
7.2 Europe Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (2021–2026)
7.4 Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size (2021–2032)
8.2 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region (2021–2026)
8.4 Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Automated And Closed Cell Therapy Processing Systems Market Size (2021–2032)
9.2 Latin America Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2021–2026)
9.4 Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size (2021–2032)
10.2 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country (2021–2026)
10.4 Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cytiva
11.1.1 Cytiva Company Details
11.1.2 Cytiva Business Overview
11.1.3 Cytiva Automated And Closed Cell Therapy Processing Systems Introduction
11.1.4 Cytiva Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.1.5 Cytiva Recent Development
11.2 Miltenyi Biotec
11.2.1 Miltenyi Biotec Company Details
11.2.2 Miltenyi Biotec Business Overview
11.2.3 Miltenyi Biotec Automated And Closed Cell Therapy Processing Systems Introduction
11.2.4 Miltenyi Biotec Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.2.5 Miltenyi Biotec Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Automated And Closed Cell Therapy Processing Systems Introduction
11.3.4 Thermo Fisher Scientific Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Terumo
11.4.1 Terumo Company Details
11.4.2 Terumo Business Overview
11.4.3 Terumo Automated And Closed Cell Therapy Processing Systems Introduction
11.4.4 Terumo Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.4.5 Terumo Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Automated And Closed Cell Therapy Processing Systems Introduction
11.5.4 Merck Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.5.5 Merck Recent Development
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Details
11.6.2 Fresenius Kabi Business Overview
11.6.3 Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Introduction
11.6.4 Fresenius Kabi Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.6.5 Fresenius Kabi Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Details
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Automated And Closed Cell Therapy Processing Systems Introduction
11.7.4 Sartorius Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.7.5 Sartorius Recent Development
11.8 Lonza
11.8.1 Lonza Company Details
11.8.2 Lonza Business Overview
11.8.3 Lonza Automated And Closed Cell Therapy Processing Systems Introduction
11.8.4 Lonza Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.8.5 Lonza Recent Development
11.9 Boyalife (ThermoGenesis)
11.9.1 Boyalife (ThermoGenesis) Company Details
11.9.2 Boyalife (ThermoGenesis) Business Overview
11.9.3 Boyalife (ThermoGenesis) Automated And Closed Cell Therapy Processing Systems Introduction
11.9.4 Boyalife (ThermoGenesis) Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.9.5 Boyalife (ThermoGenesis) Recent Development
11.10 EurekaBio
11.10.1 EurekaBio Company Details
11.10.2 EurekaBio Business Overview
11.10.3 EurekaBio Automated And Closed Cell Therapy Processing Systems Introduction
11.10.4 EurekaBio Revenue in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
11.10.5 EurekaBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Stem Cell Therapy
Table 3. Key Players of Non-Stem Cell Therapy
Table 4. Global Automated And Closed Cell Therapy Processing Systems Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Automated And Closed Cell Therapy Processing Systems Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Automated And Closed Cell Therapy Processing Systems Market Size by Region (US$ Million), 2021–2026
Table 7. Global Automated And Closed Cell Therapy Processing Systems Market Share by Region (2021–2026)
Table 8. Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Automated And Closed Cell Therapy Processing Systems Market Share by Region (2027–2032)
Table 10. Automated And Closed Cell Therapy Processing Systems Market Trends
Table 11. Automated And Closed Cell Therapy Processing Systems Market Drivers
Table 12. Automated And Closed Cell Therapy Processing Systems Market Challenges
Table 13. Automated And Closed Cell Therapy Processing Systems Market Restraints
Table 14. Global Automated And Closed Cell Therapy Processing Systems Revenue by Players (US$ Million), 2021–2026
Table 15. Global Automated And Closed Cell Therapy Processing Systems Market Share by Players (2021–2026)
Table 16. Global Top Automated And Closed Cell Therapy Processing Systems Players by Tier (Tier 1, Tier 2, and Tier 3), based on Automated And Closed Cell Therapy Processing Systems Revenue, 2025
Table 17. Ranking of Global Top Automated And Closed Cell Therapy Processing Systems Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Automated And Closed Cell Therapy Processing Systems Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Automated And Closed Cell Therapy Processing Systems, Headquarters and Area Served
Table 20. Global Key Players of Automated And Closed Cell Therapy Processing Systems, Products and Applications
Table 21. Global Key Players of Automated And Closed Cell Therapy Processing Systems, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Automated And Closed Cell Therapy Processing Systems Market Size by Type (US$ Million), 2021–2026
Table 24. Global Automated And Closed Cell Therapy Processing Systems Revenue Market Share by Type (2021–2026)
Table 25. Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Automated And Closed Cell Therapy Processing Systems Revenue Market Share by Type (2027–2032)
Table 27. Global Automated And Closed Cell Therapy Processing Systems Market Size by Application (US$ Million), 2021–2026
Table 28. Global Automated And Closed Cell Therapy Processing Systems Revenue Market Share by Application (2021–2026)
Table 29. Global Automated And Closed Cell Therapy Processing Systems Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Automated And Closed Cell Therapy Processing Systems Revenue Market Share by Application (2027–2032)
Table 31. North America Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Automated And Closed Cell Therapy Processing Systems Market Size by Country (US$ Million), 2021–2026
Table 33. North America Automated And Closed Cell Therapy Processing Systems Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Automated And Closed Cell Therapy Processing Systems Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Automated And Closed Cell Therapy Processing Systems Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size by Country (US$ Million), 2027–2032
Table 46. Cytiva Company Details
Table 47. Cytiva Business Overview
Table 48. Cytiva Automated And Closed Cell Therapy Processing Systems Product
Table 49. Cytiva Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 50. Cytiva Recent Development
Table 51. Miltenyi Biotec Company Details
Table 52. Miltenyi Biotec Business Overview
Table 53. Miltenyi Biotec Automated And Closed Cell Therapy Processing Systems Product
Table 54. Miltenyi Biotec Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 55. Miltenyi Biotec Recent Development
Table 56. Thermo Fisher Scientific Company Details
Table 57. Thermo Fisher Scientific Business Overview
Table 58. Thermo Fisher Scientific Automated And Closed Cell Therapy Processing Systems Product
Table 59. Thermo Fisher Scientific Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 60. Thermo Fisher Scientific Recent Development
Table 61. Terumo Company Details
Table 62. Terumo Business Overview
Table 63. Terumo Automated And Closed Cell Therapy Processing Systems Product
Table 64. Terumo Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 65. Terumo Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Automated And Closed Cell Therapy Processing Systems Product
Table 69. Merck Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 70. Merck Recent Development
Table 71. Fresenius Kabi Company Details
Table 72. Fresenius Kabi Business Overview
Table 73. Fresenius Kabi Automated And Closed Cell Therapy Processing Systems Product
Table 74. Fresenius Kabi Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 75. Fresenius Kabi Recent Development
Table 76. Sartorius Company Details
Table 77. Sartorius Business Overview
Table 78. Sartorius Automated And Closed Cell Therapy Processing Systems Product
Table 79. Sartorius Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 80. Sartorius Recent Development
Table 81. Lonza Company Details
Table 82. Lonza Business Overview
Table 83. Lonza Automated And Closed Cell Therapy Processing Systems Product
Table 84. Lonza Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 85. Lonza Recent Development
Table 86. Boyalife (ThermoGenesis) Company Details
Table 87. Boyalife (ThermoGenesis) Business Overview
Table 88. Boyalife (ThermoGenesis) Automated And Closed Cell Therapy Processing Systems Product
Table 89. Boyalife (ThermoGenesis) Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 90. Boyalife (ThermoGenesis) Recent Development
Table 91. EurekaBio Company Details
Table 92. EurekaBio Business Overview
Table 93. EurekaBio Automated And Closed Cell Therapy Processing Systems Product
Table 94. EurekaBio Revenue in Automated And Closed Cell Therapy Processing Systems Business (US$ Million), 2021–2026
Table 95. EurekaBio Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Automated And Closed Cell Therapy Processing Systems Picture
Figure 2. Global Automated And Closed Cell Therapy Processing Systems Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Automated And Closed Cell Therapy Processing Systems Market Share by Type: 2025 vs 2032
Figure 4. Stem Cell Therapy Features
Figure 5. Non-Stem Cell Therapy Features
Figure 6. Global Automated And Closed Cell Therapy Processing Systems Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Automated And Closed Cell Therapy Processing Systems Market Share by Application: 2025 vs 2032
Figure 8. Academia Case Studies
Figure 9. Industry Case Studies
Figure 10. Automated And Closed Cell Therapy Processing Systems Report Years Considered
Figure 11. Global Automated And Closed Cell Therapy Processing Systems Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Automated And Closed Cell Therapy Processing Systems Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Automated And Closed Cell Therapy Processing Systems Market Share by Region: 2025 vs 2032
Figure 14. Global Automated And Closed Cell Therapy Processing Systems Market Share by Players in 2025
Figure 15. Global Automated And Closed Cell Therapy Processing Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Automated And Closed Cell Therapy Processing Systems Revenue in 2025
Figure 17. North America Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Automated And Closed Cell Therapy Processing Systems Market Share by Country (2021–2032)
Figure 19. United States Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Automated And Closed Cell Therapy Processing Systems Market Share by Country (2021–2032)
Figure 23. Germany Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market Share by Region (2021–2032)
Figure 31. China Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Automated And Closed Cell Therapy Processing Systems Market Share by Country (2021–2032)
Figure 39. Mexico Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market Share by Country (2021–2032)
Figure 43. Israel Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Automated And Closed Cell Therapy Processing Systems Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Cytiva Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 47. Miltenyi Biotec Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 49. Terumo Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 50. Merck Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 51. Fresenius Kabi Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 52. Sartorius Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 53. Lonza Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 54. Boyalife (ThermoGenesis) Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 55. EurekaBio Revenue Growth Rate in Automated And Closed Cell Therapy Processing Systems Business (2021–2026)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed